Cargando…

The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia

Background: In the treatment of bloodstream infections, the identification of the causal pathogen, and the evaluation of its susceptibility to antibiotics, often serve as the rate-limiting steps of the patient’s hospital stay. The GenMark Dx ePlex blood culture identification gram-positive (BCID-GP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiszla, B. Matthew, McCarty, Todd, White, Cameron, Moates, Derek, Leal, Sixto, Lee, Rachael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Diagnostic/Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614915/ http://dx.doi.org/10.1017/ash.2022.141

Ejemplares similares

214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

200. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Positive Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)

359. The Clinical Utility of the GenMark Dx ePlex® Fungal Blood Culture Identification Panel
por: Carmona, Stefania, et al.
Publicado: (2022)

1022. Evaluating the Impact of GenMark Dx ePlex® Blood Culture Identification (BCID) on Gram-negative Bloodstream Infections
por: Cumagun, Pia, et al.
Publicado: (2021)

Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: McCarty, T. P., et al.
Publicado: (2023)

1027. Earlier Is Better: Progress Toward Decreased Time to Optimal Therapy and Improved Antibiotic Stewardship for Gram-positive Bloodstream Infections Through Use of GenMark Dx ePlex system
por: White, Cameron, et al.
Publicado: (2021)

Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel
por: Carroll, Karen C., et al.
Publicado: (2020)

A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel
por: Wolk, Donna M., et al.
Publicado: (2021)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

Evaluation of the Genmark ePlex® and QIAstat-Dx® respiratory pathogen panels in detecting bacterial targets in lower respiratory tract specimens
por: van Asten, Suzanne A. V., et al.
Publicado: (2021)

1143 GenMark ESensor Respiratory Viral Panel in an Inpatient Pediatric Population
por: Oliver, Sara, et al.
Publicado: (2014)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

285. Evaluation of the ePlex® Blood Culture Identification (BCID) Panels for Gram-positive/Gram-negative bacteria and yeasts
por: Chapin, Kimberle, et al.
Publicado: (2020)

Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex(®) Blood Culture Identification Panels for the Rapid Diagnosis of Bacteremia and Fungemia
por: Bryant, Sabrina, et al.
Publicado: (2020)

Evaluation of point of care testing platform (ePLEX) for respiratory viral diagnosis
por: Guerendiain, Daniel, et al.
Publicado: (2016)

Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections
por: Huang, Te-Din, et al.
Publicado: (2019)

653. Comparison of Yeasts identification by Biofire, Culture and ePlex for Quality Assurance purpose
por: lin, jeffrey, et al.
Publicado: (2020)

164. Performance of ePlex® Blood Culture Identification Panels in Clinical Isolates and Characterization of Antimicrobial Stewardship Opportunities
por: Thomas, Jenni, et al.
Publicado: (2023)

Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs
por: Babady, N. Esther, et al.
Publicado: (2018)

Clinical implications of rapid ePlex® Respiratory Pathogen Panel testing compared to laboratory-developed real-time PCR
por: van Rijn, Anneloes L., et al.
Publicado: (2017)

Comparison of ePlex Respiratory Pathogen Panel with Laboratory-Developed Real-Time PCR Assays for Detection of Respiratory Pathogens
por: Nijhuis, R. H. T., et al.
Publicado: (2017)

Comparative Performance of the Luminex NxTAG Respiratory Pathogen Panel, GenMark eSensor Respiratory Viral Panel, and BioFire FilmArray Respiratory Panel
por: Popowitch, Elena B., et al.
Publicado: (2022)

248. Thirty-Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species
por: White, Cameron, et al.
Publicado: (2019)

258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
por: McCarty, Todd, et al.
Publicado: (2019)

To PLEX or Not to PLEX for Amiodarone-Induced Thyrotoxicosis
por: Ahuja, Tania, et al.
Publicado: (2023)

A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures
por: Tansarli, Giannoula S., et al.
Publicado: (2022)

FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019)

An in‐house 45‐plex array for the detection of antimicrobial resistance genes in Gram‐positive bacteria
por: Kowalewicz, Carole, et al.
Publicado: (2022)

THE OCCURRENCE OF POLYGLYCEROPHOSPHATE AS AN ANTIGENIC COMPONENT OF VARIOUS GRAM-POSITIVE BACTERIAL SPECIES
por: McCarty, Maclyn
Publicado: (1959)

Fetal haemopoiesis marking low-grade urinary bladder cancer
por: Wolk, M, et al.
Publicado: (2012)

Interim evaluation of insertable cardiac monitor signal quality in the LUX-Dx PERFORM study
por: Richards, M, et al.
Publicado: (2023)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet Syndrome
por: Stenhouse, Susan A.R., et al.
Publicado: (2013)

Impact of CLSI Break Point Changes Over the Past Decade on Antimicrobial Susceptibility in Gram-Negative Bacteria
por: Johnson, Wesley, et al.
Publicado: (2021)

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours
por: Weidlich, S, et al.
Publicado: (2011)

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
por: Wey, J S, et al.
Publicado: (2005)

Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays
por: Quinton, Mikayla, et al.
Publicado: (2022)

Evaluation of insertable cardiac monitor placement and safety in the LUX-Dx PERFORM study
por: Richards, M, et al.
Publicado: (2023)

High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers
por: Lin, Jia-Ren, et al.
Publicado: (2023)

Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vml1egitr83r161qja8h5n3rfk